Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor (Q43966314)

28 November 2017

title

Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor (English)

1 reference

28 November 2017

1 reference

28 November 2017

Karen M Grant

0 references

Laurent Meijer

1 reference

28 November 2017

Marie Knockaert

1 reference

28 November 2017

Karen Wieking

1 reference

28 November 2017

Sophie Schmitt

1 reference

28 November 2017

Maryse Leost

1 reference

28 November 2017

Conrad Kunick

1 reference

28 November 2017

language of work or name

English

0 references

publication date

18 April 2002

1 reference

Journal of Biological Chemistry

28 November 2017

published in

1 reference

28 November 2017

volume

277

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

25493-25501

1 reference

ATP site-directed competitive and irreversible inhibitors of protein kinases

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Protein kinases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Inhibition of cyclin-dependent kinases by purine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

CDK inhibition and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Cyclin-dependent kinase inhibitors: novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

The crk3 gene of Leishmania mexicana encodes a stage-regulated cdc2-related histone H1 kinase that associates with p12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Purification and properties of Plasmodium falciparum malate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Malate dehydrogenase: a model for structure, evolution, and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Refined crystal structure of mitochondrial malate dehydrogenase from porcine heart and the consensus structure for dicarboxylic acid oxidoreductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Refined crystal structure of cytoplasmic malate dehydrogenase at 2.5-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Mechanisms of action of flavopiridol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Small molecule modulators of cyclin-dependent kinases for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Potent interaction of flavopiridol with MRP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Tetrameric and dimeric malate dehydrogenase isoenzymes in Trypanosoma cruzi epimastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Trypanosoma brucei: molecular cloning and stage-regulated expression of a malate dehydrogenase localized to the mitochondrion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Molecular cloning of the glycosomal malate dehydrogenase of Trypanosoma brucei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Purification of particulate malate dehydrogenase and phosphoenolpyruvate carboxykinase from Leishmania mexicana mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

Leishmania mexicana: Subcellular distribution of enzymes in amastigotes and promastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202651200

21 January 2018

Identifiers

DOI

10.1074/JBC.M202651200

1 reference

28 November 2017

1 reference